| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5fb96a8bb51de834edd7b58df0c695ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f4b6763aad51c0b800dc493ed85b401a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_51324311cd4014737196b634a06de88c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4625693976f068a11336e2989a6d76f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b775b78aba5336e6dddace8c2a4f3c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_35e0cdb2096a79592c1fcdd88643efa3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_906e171e04ac779237798e95a3b74a51 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B53-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
| filingDate |
2001-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5415c711525d88d24b75f14b95eb85c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b2a082b175b0fa86270f0c2e13af607
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0d1ce0e6a8432c8c9d594bcbd878e06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03d06ebe2a4444aaa6fab3f0a8995e6f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3535542824727c9eb21c569151153d4f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a518797014c417b54382259a9d1a0045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8f50bef16ee613561701072af6ae43e |
| publicationDate |
2002-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0228840-A1 |
| titleOfInvention |
Process for preparation of integrin receptor antagonist intermediates |
| abstract |
A novel process is provided for the preparation of chiral intermediates useful in the asymmetric syntheses of αvβ3 integrin receptor antagonists. Also provided are the enantiomerically enriched intermediates that are obtained from the process. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2258676-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007524712-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2258676-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009119817-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11426473-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8373007-B2 |
| priorityDate |
2000-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |